Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · IEX Real-Time Price · USD

17.14

0.00 (0.00%)

At close: May 6, 2024, 4:00 PM

17.29

+0.15 (0.88%)

After-hours: May 6, 2024, 7:38 PM EDT

Denali Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-145.22	-325.99	-290.58	71.14	-197.61	-36.24	-88.19	-86.65	-16.79
Depreciation & Amortization	16.73	10.38	8.59	8.53	7.99	7.42	3.08	1.47	0.12
Share-Based Compensation	108.1	99.85	85.25	50.35	38.38	18.79	4.41	2.95	0.48
Other Operating Activities	-337.6	-28.96	-14.65	286.13	-0.33	60.15	4.06	10.32	1.14
Operating Cash Flow	-357.99	-244.72	-211.39	416.15	-151.58	50.12	-76.64	-71.91	-15.05
Capital Expenditures	-12.94	-17.83	-8.5	-3.1	-17.92	-3.39	-2.88	-6.13	-3.06
Change in Investments	262.25	-123.55	-13.13	-620.11	165.63	-284.03	-38.29	-212.87	0
Investing Cash Flow	249.31	-141.39	-21.63	-623.21	147.71	-287.42	-41.17	-219	-3.06
Share Issuance / Repurchase	17.82	310.67	19.35	634.75	6.19	98.41	266.35	0.11	0.62
Other Financing Activities	-	-	-	-	-	-1.39	29.97	300.37	48.23
Financing Cash Flow	17.82	310.67	19.35	634.75	6.19	97.02	296.32	300.48	48.85
Net Cash Flow	-90.86	-75.43	-213.67	427.7	2.33	-140.29	178.52	9.56	30.74
Free Cash Flow	-370.93	-262.55	-219.89	413.06	-169.5	46.72	-79.51	-78.04	-18.11
Free Cash Flow Margin	-112.22%	-242.06%	-451.88%	123.06%	-635.34%	36.17%	-	-	-
Free Cash Flow Per Share	-2.70	-2.09	-1.81	3.44	-1.77	0.50	-5.31	-12.15	-6.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).